Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.59 |
| ▸ | TSHR | P16473 | 5/20 | 0.58 |
| ▸ | F2 | P00734 | 1/20 | 0.56 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.52 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.48 |
| ▸ | CES2 | O00748 | 1/20 | 0.48 |
| ▸ | CES1 | P23141 | 1/20 | 0.48 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | PARP1 | P09874 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Propane SCHEMBL3711418 | 0.98 | LMNA (0.57) | LMNATSHRF2TDP1KMT2A | |
| Alcohol SCHEMBL28089300 | 0.95 | LMNA (0.59) | LMNATSHRF2TDP1KMT2A | |
| Butane SCHEMBL27396437 | 0.93 | LMNA (0.62) | LMNATSHRF2TDP1KMT2A | |
| Ethane SCHEMBL455951 | 0.91 | TSHR (0.62) | LMNATSHRF2TDP1KMT2A | |
| SCHEMBL27265493 | 0.91 | LMNA (0.67) | LMNATSHRF2TDP1KMT2A | |
| SCHEMBL1816 | 0.91 | LMNA (0.67) | LMNATSHRF2TDP1KMT2A | |
| Hydrogen Peroxide SCHEMBL11489043 | 0.91 | LMNA (0.67) | LMNATSHRF2TDP1KMT2A | |
| Benzene SCHEMBL10686034 | 0.91 | LMNA (0.67) | LMNATSHRF2TDP1KMT2A | |
| Hydrogen Peroxide SCHEMBL2929887 | 0.91 | LMNA (0.67) | LMNATSHRF2TDP1KMT2A | |
| Butanone SCHEMBL10420714 | 0.90 | LMNA (0.53) | LMNATSHRF2TDP1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2170 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4604724-A1 | SUSPENSION CONCENTRATE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION | Texas Crop Science, Inc. (US) | 2025-08-27 | — | — | EP | claimed |
| CN-119606779-A | External cream for directional delivery of tranexamic acid to epidermis layer and preparation method thereof | 上海力芯联创生物医药科技有限公司 | 2025-03-14 | — | — | CN | claimed |
| US-12016833-B2 | Combination formulation containing colchicine for treatment or enhancing the therapy of liver disease | ACEBIOMED, INC. (KR) | 2024-06-25 | — | — | US | claimed |
| WO-2024086345-A1 | SUSPENSION CONCENTRATE ACYLHYDRAZONE APYRASE INHIBITOR FORMULATION | TEXAS CROP SCIENCE, INC. (US) | 2024-04-25 | — | — | WO | claimed |
| EP-4245758-A2 | CRYSTALLINE SALTS OF A B-RAF KINASE INHIBITOR | Xynomic Pharmaceuticals, Inc. (US) | 2023-09-20 | — | — | EP | claimed |
| EP-3854390-A1 | FORMULATION COMPRISING COLCHICINE AND METFORMINE FOR TREATMENT OR ENHANCING THE THERAPY OF LIVER DISEASE | Acebiomed, Inc. (KR) | 2021-07-28 | — | — | EP | claimed |
| US-20210220296-A1 | COMBINATION FORMULATION CONTAINING COLCHICINE FOR TREATMENT OR ENHANCING THE THERAPY OF LIVER DISEASE | ACEBIOMED, INC. | 2021-07-22 | — | — | US | claimed |
| US-20210137858-A1 | COMBINATION FORMULATION CONTAINING COLCHICINE FOR TREATMENT OR ENHANCING THE THERAPY OF LIVER DISEASE | ACEBIOMED, INC. | 2021-05-13 | — | — | US | claimed |
| US-20100081639-A1 | PHARMACEUTICAL COMPOSITION COMPRISING FERMENTED GINSENG | KIM DONG-HYUN | 2010-04-01 | — | — | US | claimed |
| US-20040068064-A1 | Method for producing homo-and co-polymers of ethylene | HANWHA TOTAL PETROCHEMICAL CO., LTD. (KR) | 2004-04-08 | — | — | US | claimed |
| EP-4748400-A1 | CONJUGATE FOR ANTIGEN DELIVERY AND USE THEREOF | LG Chem, Ltd. (KR) | 2026-05-27 | — | — | EP | disclosed |
| US-12637688-B2 | DNA construct for diagnosing and treating cancer | CNCURE BIOTECH INC. (KR) | 2026-05-26 | — | — | US | disclosed |
| US-12637429-B2 | Oxidized lappaconitine derivative and use thereof | QGENETICS CO., LTD. (KR) | 2026-05-26 | — | — | US | disclosed |
| EP-4744674-A1 | GASTRIC ACID-STABLE PROBIOTIC PREPARATION AND METHOD FOR PREPARING SAME | Valvet Care Co., Ltd. (KR) | 2026-05-20 | — | — | EP | disclosed |
| EP-3828163-B1 | NOVEL P62 LIGAND COMPOUND, AND COMPOSITION FOR PREVENTING, ALLEVIATING, OR TREATING PROTEINOPATHIES COMPRISING SAME | AUTOTAC INC (KR) | 2026-05-20 | — | — | EP | disclosed |
| US-5364890-A | (meth)acrylate and a carbodiimide | GC CORPORATION (JP) | 1994-11-15 | — | — | US | disclosed |
| EP-0330756-A2 | Thienotricyclics for the treatment of bronchial diseases | Byk Gulden Lomberg Chemische Fabrik GmbH (DE) | 1989-09-06 | — | — | EP | disclosed |
| EP-0287339-A2 | Piperidine opioid antagonists | ELI LILLY AND COMPANY (US) | 1988-10-19 | — | — | EP | disclosed |
| US-4205088-A | GASTROINTESTINAL DISORDERS, CARDIOVASCULAR DISORDERS | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) | 1980-05-27 | — | — | US | disclosed |
| US-4034111-A | INTESTINAL SECRETION AND CARDIAC STIMULATION | BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DT) | 1977-07-05 | — | — | US | disclosed |